As of Oct 20
| +0.65 / +2.36%|
The 4 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 49.00, with a high estimate of 85.00 and a low estimate of 35.00. The median estimate represents a +74.13% increase from the last price of 28.14.
The current consensus among 5 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.